Enter your terms above and click the 'Search' button.

Showing articles 0 to 2 of 2 Filter Applied: efficacy (Click to remove) Inhibition of CD40L with Frexalimab in Multiple Sclerosis NEJM 390:589-600, 662, Vermersch,P.,et al, 2024 Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinsons Disease NEJM 382:1926-1932, Schweitzer, J.S.,et al, 2020 Showing articles 0 to 2 of 2